paeonol has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, H; Guo, R; Jiang, W; Sun, D; Wang, R; Wu, J; Xue, X; Zhang, B | 1 |
| Cao, H; Guo, R; Jiang, W; Kong, F; Li, J; Sun, D; Wu, J; Xue, X; Zhang, B | 1 |
2 other study(ies) available for paeonol and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
The protective effects of paeonol against epirubicin-induced hepatotoxicity in 4T1-tumor bearing mice via inhibition of the PI3K/Akt/NF-kB pathway.
Topics: Acetophenones; Animals; Cell Line, Tumor; Cell Proliferation; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Epirubicin; Female; Hepatocytes; Mammary Neoplasms, Experimental; Mice; NF-kappa B; Oxidative Stress; Paeonia; Phosphatidylinositol 3-Kinases; Protective Agents; Proto-Oncogene Proteins c-akt; Signal Transduction; Structure-Activity Relationship | 2016 |
Enhanced antitumor activity and attenuated cardiotoxicity of Epirubicin combined with Paeonol against breast cancer.
Topics: Acetophenones; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Breast Neoplasms; Cardiotoxicity; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Epirubicin; Female; Humans; Immunohistochemistry; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice, Inbred BALB C; Microscopy, Fluorescence; Mitogen-Activated Protein Kinases; Tumor Burden | 2016 |